ISSN: 1755-5914

Journal Home

Cardiovascular Therapeutics Q2 Unclaimed

Wiley-Blackwell Publishing Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cardiovascular Therapeutics is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 54. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1440 €. The scope of the journal is focused on cardiovascular pharmacology, cardiovascular drugs, cardiovascular diseases. It has an SJR impact factor of 0,769 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,769.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Cardiology and Cardiovascular Medicine (Q2) Medicine (miscellaneous) (Q2) Pharmacology (Q2) Pharmacology (medical) (Q2) Pharmacology (medical) (Q2)

Price

1440 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,769

SJR Impact factor

54

H Index

34

Total Docs (Last Year)

165

Total Docs (3 years)

1509

Total Refs

544

Total Cites (3 years)

165

Citable Docs (3 years)

3.43

Cites/Doc (2 years)

44.38

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Cardiovascular pharmacology Cardiovascular drugs Cardiovascular diseases

Best articles by citations

Regenerative Therapy in Peripheral Artery Disease

Pharmacokinetic Interaction of the Direct Renin Inhibitor Aliskiren with Furosemide and Extended-Release Isosorbide-5-Mononitrate in Healthy Subjects

External Validity of the ARISTOTLE Trial in Real-Life Atrial Fibrillation Patients

Administration of Antiarrhythmic Drugs to Maintain Sinus Rhythm After Catheter Ablation for Atrial Fibrillation: A Meta-Analysis

Allopurinol Treatment Reduces Arterial Wave Reflection in Stroke Survivors

Antihypertensive Drugs and New-Onset Diabetes: A Retrospective Longitudinal Cohort Study

Resistant Hypertension and Renal Denervation Where to Now?

About "Resting Heart Rate Does Not Reflect the Degree of Beta-Blockade in Subjects with Heart Failure on Chronic Beta-Blocker Therapy"

What Should Medical Practitioners Know about the Role of Alternative Medicines in Cardiovascular Disease Management?

Plaque Thrombosis is Reduced by Attenuating Plaque Inflammation with Pioglitazone and is Evaluated by Fluorodeoxyglucose Positron Emission Tomography

Effects of Multiple Doses of Clarithromycin on the Pharmacokinetics of Laropiprant in Healthy Subjects

A Dosing Algorithm for Erythropoietin Alpha in Older Adults with Heart Failure and a Preserved Ejection Fraction

SHOW MORE ARTICLES

Nonequivalence of Inhaled and Nebulized Salbutamol in the Assessment of Endothelial Dysfunction

Secondary Prevention in Concurrent Coronary Artery, Cerebrovascular, and Chronic Kidney Disease: Focus on Pharmacological Therapy

Pentoxifylline in Heart Failure: A Meta-Analysis of Clinical Trials

Medical Malpractice: A Cardiovascular Perspective

Beneficial Effects of L- and N-type Calcium Channel Blocker on Glucose and Lipid Metabolism and Renal Function in Patients with Hypertension and Type II Diabetes Mellitus

Assessment of Arterial Stiffness, A Translational Medicine Biomarker System for Evaluation of Vascular Risk

Hypertension, Dietary Salt Intake, and the Role of the Thiazide-Sensitive Sodium Chloride Transporter NCCT

Differences in Medical Treatment of Chronic Coronary Heart Disease Patients According to Medical Specialities

Nutraceuticals and Atherosclerosis: Human Trials

Nutraceuticals in Diabetes and Metabolic Syndrome

The Next Generation of Review for Cardiac Cell Therapies

The Association Between Bleeding and the Incidence of Warfarin Discontinuation in Patients with Atrial Fibrillation